Summary: Spectrum Dynamics Medical and DeepDense Medical have partnered to integrate AI-based applications into cardiac and spine imaging, aiming to improve diagnostic accuracy and streamline workflows.

Key Takeaways

  • Partnership Focus: Spectrum Dynamics Medical and DeepDense Medical are collaborating to develop AI-based applications for cardiac and spine disease analysis, aiming to improve visualization and diagnostic accuracy.
  • Customer Benefits: Spectrum Dynamics’ customers will have access to DeepDense’s AI tools, which can be integrated into existing imaging systems to streamline workflows and improve patient care.
  • Technological Integration: The partnership seeks to enhance Spectrum Dynamics’ SPECT/CT platforms with AI for automatic analysis, improved image quality, and reduced scan times.

————————————————————————————————————————————————————————————

Spectrum Dynamics Medical has partnered with DeepDense Medical to develop AI-based applications for cardiac and spine disease analysis. The collaboration aims to improve visualization and analysis of these conditions by integrating DeepDense’s AI algorithms with Spectrum Dynamics’ imaging systems, enhancing diagnostic accuracy and streamlining workflows.

Customers of Spectrum Dynamics will have access to DeepDense’s AI applications, which offer visualization and editing tools. These applications can be added to Spectrum Dynamics’ existing solutions to reduce healthcare costs and improve patient care. DeepDense’s 3D labeling tools also support the development of AI applications.

“The integration of digital SPECT technology with advanced AI features will open new capabilities in imaging and treatment,” says Gilad Yoeli, CEO of Spectrum Dynamics Medical.

What’s more, Yoeli says, “This partnership with DeepDense will enable Spectrum Dynamics to enhance our VERITON-CT SPECT/CT and D-SPECT platforms with customized AI capabilities to enable automatic quantitative analysis, improve image quality and reduce scan times. This agreement demonstrates our resolve to continue to be in the forefront of molecular imaging technology.”

Yechiel Lamash, founder of DeepDense Medical, also spoke out about the partnership, adding: “Our collaboration has uncovered new opportunities for using AI to enhance patient care.”